| http://www.w3.org/ns/prov#value | - The over-expression of CYP11B and under-expression of HSD11B2 as compared to normal skin indicates aberrant production of GC in the non-healing tissue.Yet another embodiment of the present invention is a method of increasing the effectiveness of an exogenous glucocorticoid treatment, by administering or applying the glucocorticoid with an inhibitor of HSD11B2 or another enzyme that controls the pr
|
